Collectively, these studies establish IGF2BP2 as a key oncogenic driver in thyroid cancer, however, they have examined PTC and ATC as separate entities without considering the continuous differentiation spectrum that characterizes thyroid tumors. This evidence concerns the gene IGF2BP2 and thyroid gland carcinoma.